Labiotech.eu

News and Trends 6 Jun 2022

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

4BIO Capital, an international venture capital firm focusing on the advanced therapies sector, has co-led a $30.3M oversubscribed Series B financing in LUCA Science Inc., which is developing a novel class of mitochondria biopharmaceutical agents. The round was co-led with DCI Partners and existing investor Fast Track Initiative, and supported by existing international investors including […]

June 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Jun 2022

Type 1 diabetes in the crosshairs with Imagine Pharma discovery

U.S. biotech company Imagine Pharma is showcasing its discovery of Type 1 Diabetes Activated Islet Progenitor Cells (T1D AIPCs) at the American Transplant Congress in Boston. The company said its industry breakthrough is a critical component for the potential treatment of T1D through autologous cell transplantation. T1D AIPCs are novel cell populations generated and propagated […]

June 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Jun 2022

Report shows growth of life sciences sector in eastern Denmark

A new report on the Danish contribution to the Medicon Valley has been published. The report, Life Science in Eastern Denmark – The Danish Part of Medicon Valley is a survey of companies in the sector. Medicon Valley spans the Danish region of Zealand and the Capital Region, and the Skåne region of southern Sweden. […]

June 6, 2022 - 3 minutesmins - By Jim Cornall

In Depth 6 Jun 2022

Releasing the microbiome’s potential to restore European soils

For decades, soil has been treated as an everlasting food machine rather than as a fragile living thing, and it is reaching a crisis point. Understanding how the soil microbiome interacts with the environment and helping farmers embrace new sustainable methods can have a beneficial impact on the soil, and consequently, our health. After years […]

June 6, 2022 - 9 minutesmins - By Carlos de Rojas

News and Trends 2 Jun 2022

Upstream Bio to target asthma as it launches with $200M financing

Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M Series A financing. The company said the funding will allow it to advance its lead program UPB-101, a clinical-stage monoclonal antibody targeting the thymic stromal lymphopoietin (TSLP) receptor. It added the investment will also help build a pipeline of assets […]

June 2, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility

Singapore biotech firm MiRXES Pte Ltd, which focuses on early detection cancer tests, has opened the first industry 4.0 (i4.0) in vitro diagnostic (IVD) manufacturing facility in Southeast Asia. The S$8M (US$5.8M) 15,000-square-feet facility is located at JTC MedTech Hub. The company said the site is close to the biomedical R&D community at Biopolis, pharmaceutical […]

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

Chinese biotech company looks to help global monkeypox drug development

Shanghai Zelixir Biotech Company Ltd. has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes, which is the complete set of proteins present at a given time in the cell. The company hopes the predicted structures will help the global quest to develop monkeypox vaccines. Monkeypox cases have grown […]

June 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

New treatment option available for Dravet syndrome

Global biopharma company UCB says the UK’s National Institute for Healthcare Excellence (NICE) has issued a positive Final Appraisal Determination (FAD) for its FINTEPLA (fenfluramine) oral solution. FINTEPLA is used for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients two years of age and older. […]

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 1 Jun 2022

GSK to acquire clinical-stage biopharmaceutical company Affinivax

GSK plc is set to acquire Affinivax, Inc., a clinical-stage biopharmaceutical company based in Cambridge, Boston, Massachusetts, for a $2.1B upfront payment and up to $1.2B in potential development milestones. Affinivax is developing a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines. Pneumococcal disease includes pneumonia, meningitis, bloodstream infections, and […]

June 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 31 May 2022

Therapeutic RNA company receives additional funding

UK biotech company Transine Therapeutics, which is developing a novel class of therapeutic RNAs, has successfully raised £4.6M ($5.8M) in additional seed funding. The financing was led by new investor Epidarex Capital with participation from existing investor the Dementia Discovery Fund (DDF). Transine said the additional funds will enable it to further develop its SINEUP […]

May 31, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 31 May 2022

Evotec adds cell therapy manufacturing facility through Rigenerand takeover

German headquartered life science company Evotec SE has acquired 100% of the capital of Rigenerand Srl, an Italian cell technology company, for €23M ($24.7M). Founded in 2009 as a spin-off of the University of Modena and Reggio Emilia in Italy, Rigenerand is based in Medolla, Italy, about 100 km south of Evotec’s Campus Levi-Montalcini in […]

May 31, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 31 May 2022

Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments

UK neuroscience company NRG Therapeutics Ltd has received a Biomedical Catalyst (BMC) award to fund preclinical development of its small molecule disease-modifying medicines for the treatment of Parkinson’s disease, motor neuron disease (MND) and other debilitating chronic neurodegenerative disorders. The £2.68M ($5.8M) early-stage BMC award part-funded by the government-backed agency Innovate UK will support a […]

May 31, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Mitochondria in focus as 4BIO Capital co-leads $30.3M financing in LUCA Science

Type 1 diabetes in the crosshairs with Imagine Pharma discovery

Report shows growth of life sciences sector in eastern Denmark

Releasing the microbiome’s potential to restore European soils

Upstream Bio to target asthma as it launches with $200M financing

MiRXES opens Southeast Asia’s first industry 4.0 IVD manufacturing facility

Chinese biotech company looks to help global monkeypox drug development

New treatment option available for Dravet syndrome

GSK to acquire clinical-stage biopharmaceutical company Affinivax

Therapeutic RNA company receives additional funding

Evotec adds cell therapy manufacturing facility through Rigenerand takeover

Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!